Arabesque Asset Management LTD Gilead Sciences, Inc. Transaction History

Arabesque Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $2.57 Million - $3.68 Million	41,171 New	41,171 $3.53 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.09 Million - $1.24 Million	-19,246 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $3,042 - $3,825	49 Added 0.26%	19,246 $1.22 Million
Q2 2020 Oct 22, 2020	BUY	$72.34 - $84.0 $1,591 - $1,848	22 Added 0.11%	19,197 $1.48 Million
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $1.2 Million - $1.54 Million	19,175 New	19,175 $1.43 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.